• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.380 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
38 39 Next >
News headline image
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cassava Sciences, Inc. (SAVA)
September 03, 2021
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Cassava CEO Goes Offensive Over Data Allegations ↗
September 03, 2021
Cassava Sciences Inc (NASDAQ: SAVA) has garnered attention recently after a citizen petition with the FDA suggested that the use of Alzheimer's candidate data is based... 
Via Benzinga
News headline image
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc. (SAVA) Investors
September 03, 2021
From Kirby McInerney LLP
Via Business Wire
News headline image
Fraud Allegations Are Unlikely to Keep Cassava Stock Down ↗
September 03, 2021
Cassava's unchallenged safety and cognition data will result in the FDA allowing it to conduct a Phase 3 trial. SAVA stock is a buy. 
Via InvestorPlace
Topics Fraud
News headline image
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
News headline image
CASSAVA SHAREHOLDER ALERT
September 02, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cassava Sciences, Inc. (SAVA)
September 02, 2021
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Cassava Sciences Stock Will Fall Further on Data Manipulation Allegations ↗
September 02, 2021
SAVA stock is still one of the best performers this year, but the recent allegations mean shares will fall further as the story develops. 
Via InvestorPlace
News headline image
Here's How You Handle a Volatile Stock Like Cassava Sciences ↗
September 02, 2021
Investing in biotech stocks can pay off big, but only if their research pans out. Pay attention to the risk-reward ratio -- and control your greed. 
Via The Motley Fool
News headline image
Lawsuits Filed Against COIN, ATVI and SAVA - Jakubowitz Law Pursues Shareholders Claims
September 02, 2021
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
News headline image
CASSAVA DEADLINE ALERT
September 01, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
September 01, 2021
Gainers Neuronetics (NASDAQ:STIM) stock rose 16.51% to $7.83 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 675.7K shares... 
Via Benzinga
News headline image
Lawsuits Filed Against PLL, KPLT and SAVA - Jakubowitz Law Pursues Shareholders Claims
September 01, 2021
NEW YORK, NY / ACCESSWIRE / September 1, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
News headline image
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLCT, LIVE and SAVA
September 01, 2021
NEW YORK, NY / ACCESSWIRE / September 1, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
News headline image
SAVA ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Cassava Sciences, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
August 31, 2021
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
SHAREHOLDER ALERT: Robbins LLP Announces that Cassava Sciences, Inc. (SAVA) is Being Sued for Misleading Shareholders
August 31, 2021
From Robbins LLP
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc. (SAVA) Investors
August 31, 2021
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
CLASS ACTION UPDATE for ZY, ATIP and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
August 31, 2021
NEW YORK, NY / ACCESSWIRE / August 31, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc. (SAVA) Investors
August 31, 2021
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Lawsuits Filed Against JRVR, SAVA and HYRE - Jakubowitz Law Pursues Shareholders Claims
August 31, 2021
NEW YORK, NY / ACCESSWIRE / August 31, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
News headline image
Wait to See How the Cassava Sciences Allegations Pan Out ↗
August 31, 2021
Allegations have been leveled against Cassava Sciences. SAVA stock has fallen by more than 50% as a result. Is this a buy-on-the-dip moment? 
Via InvestorPlace
News headline image
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, SAVA and HYRE
August 31, 2021
NEW YORK, NY / ACCESSWIRE / August 31, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
News headline image
CASSAVA SCIENCES ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cassava Sciences and Encourages Investors to Contact the Firm
August 30, 2021
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
CASSAVA DEADLINE ALERT
August 30, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
SAVA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Cassava Sciences, Inc.
August 30, 2021
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Insiders Like Cassava Sciences, Which Might Be Good News ↗
August 30, 2021
Insider transactions have historically proven quite prescient for the trajectory of SAVA stock, so what do they imply today? 
Via InvestorPlace
News headline image
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OTLY, ATIP and SAVA
August 30, 2021
NEW YORK, NY / ACCESSWIRE / August 30, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Lawsuit
News headline image
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 30, 2021
From The Schall Law Firm
Via Business Wire
News headline image
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLCT, COIN and SAVA
August 30, 2021
NEW YORK, NY / ACCESSWIRE / August 30, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
August 30, 2021
Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of... 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
38 39 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap